Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pasta

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Pediatric Pulmonology|November 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosisJeffrey S Wagener, Donald R VanDevanter, Michael W Konstan, et al.
Fertility and Sterility|May 1, 1992
Comparison of CO2 laser laparoscopy with laparotomy for treatment of endometriomataG D Adamson, L L Subak, D J Pasta, et al.
Urology|September 4, 1999
Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research EndeavorM S Litwin, S C Flanders, D J Pasta, et al.
The Journal of Urology|February 15, 2001
Quality of life before death for men with prostate cancer: results from the CaPSURE databaseM S Litwin, D P Lubeck, M L Stoddard, et al.
Journal of Clinical Epidemiology|April 12, 2001
The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancerD F Penson, M L Stoddard, D J Pasta, et al.
Pediatric Pulmonology|February 24, 2012
Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.
The Journal of Urology|December 13, 2006
Quality of life for men receiving a second treatment for prostate cancerShelley A Arredondo, David M Latini, Natalia Sadetsky, et al.
Pediatric Pulmonology|October 25, 2017
Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen changeDonald R VanDevanter, Marcia L Craib, David J Pasta, et al.
Annals of the American Thoracic Society|November 16, 2017
Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary ExacerbationsMichael S Schechter, Donald R VanDevanter, David J Pasta, et al.
The Journal of Pediatrics|September 22, 2015
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung FunctionWayne J Morgan, Donald R VanDevanter, David J Pasta, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Pediatric Pulmonology|November 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosisJeffrey S Wagener, Donald R VanDevanter, Michael W Konstan, et al.
Fertility and Sterility|May 1, 1992
Comparison of CO2 laser laparoscopy with laparotomy for treatment of endometriomataG D Adamson, L L Subak, D J Pasta, et al.
Urology|September 4, 1999
Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research EndeavorM S Litwin, S C Flanders, D J Pasta, et al.
The Journal of Urology|February 15, 2001
Quality of life before death for men with prostate cancer: results from the CaPSURE databaseM S Litwin, D P Lubeck, M L Stoddard, et al.
Journal of Clinical Epidemiology|April 12, 2001
The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancerD F Penson, M L Stoddard, D J Pasta, et al.
Pediatric Pulmonology|February 24, 2012
Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.
The Journal of Urology|December 13, 2006
Quality of life for men receiving a second treatment for prostate cancerShelley A Arredondo, David M Latini, Natalia Sadetsky, et al.
Pediatric Pulmonology|October 25, 2017
Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen changeDonald R VanDevanter, Marcia L Craib, David J Pasta, et al.
Annals of the American Thoracic Society|November 16, 2017
Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary ExacerbationsMichael S Schechter, Donald R VanDevanter, David J Pasta, et al.
The Journal of Pediatrics|September 22, 2015
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung FunctionWayne J Morgan, Donald R VanDevanter, David J Pasta, et al.
Pageof 17